Penumbra
medical device company in Alameda, California
NYSE
ISIN US70975L1070 SEC CIK 1321732 LEI 549300RGE06P3ECANU72
Follow Penumbra
Weekly email: filings, results
Revenue, last quarter
$410.1M
+15.6% vs same quarter last year
Net income
$42.3M
−7.8% vs same quarter last year
EPS, diluted
$1.07
−8.5% vs same quarter last year
Operating cash flow
$41.5M
−28.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.4B | $177.7M |
| FY24 | $1.2B | $14M |
| FY23 | $1.1B | $91M |
| FY22 | $847.1M | −$2M |
| FY21 | $747.6M | $5.3M |
| FY20 | $560.4M | −$15.7M |
| FY19 | $547.4M | $48.5M |
| FY18 | $444.9M | $6.6M |
| FY17 | $333.8M | $4.7M |
| FY16 | $263.3M | $14.8M |
| FY15 | $186.1M | $2.4M |
| FY14 | $125.5M | - |
| FY13 | $88.8M | $4.1M |
| FY12 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 67.1% | 13.5% | 12.7% |
| FY24 | 63.2% | 0.8% | 1.2% |
| FY23 | 64.5% | 6.9% | 8.6% |
| FY22 | 63.2% | 0.7% | −0.2% |
| FY21 | 63.6% | −1% | 0.7% |
| FY20 | 60.3% | −6.9% | −2.8% |
| FY19 | 68% | 8.7% | 8.9% |
| FY18 | 65.7% | −0.2% | 1.5% |
| FY17 | 65.1% | 0.3% | 1.4% |
| FY16 | 64.9% | −0.5% | 5.6% |
| FY15 | 66.7% | 2.2% | 1.3% |
| FY14 | 66% | 2.4% | - |
| FY13 | 65.1% | −1.3% | 4.6% |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $174.9M |
| FY24 | $147.3M |
| FY23 | $82.1M |
| FY22 | −$75M |
| FY21 | −$11.7M |
| FY20 | −$58M |
| FY19 | $4.5M |
| FY18 | $19.2M |
| FY17 | $159K |
| FY16 | −$26.4M |
| FY15 | −$26.2M |
| FY14 | −$10.3M |
| FY13 | −$4.2M |
| FY12 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | $0 |
| FY24 | $100.4M |
| FY23 | $0 |
| FY22 | $0 |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
- Penumbra
- Healthcare median
Show the numbers
| Year | Penumbra | Healthcare median |
|---|---|---|
| FY25 | 12.7% | −30.6% |
| FY24 | 1.2% | −47% |
| FY23 | 8.6% | −58% |
| FY22 | −0.2% | −80.4% |
| FY21 | 0.7% | −71.8% |
| FY20 | −2.8% | −62.2% |
| FY19 | 8.9% | −46.2% |
| FY18 | 1.5% | −49.6% |
| FY17 | 1.4% | −45.9% |
| FY16 | 5.6% | −36% |
| FY15 | 1.3% | −37.8% |
| FY14 | - | −35.5% |
| FY13 | 4.6% | −37.1% |
| FY12 | - | −29.1% |